Literature DB >> 7471106

Survey of radiosensitivity in a variety of human cell strains.

C F Arlett, S A Harcourt.   

Abstract

gamma-Ray sensitivity for cell killing was assayed in 54 human cell strains, including some derived from individuals suffering from certain heritable diseases. The overall range of Do values in this study was 38 to 180 rads, indicating a considerable range of variability in humans. The normal sensitivity was described by a range of Do values of 97 to 180 rads. All ten ataxia telangiectasia cell strains tested proved radiosensitive and gave a mean Do value of 57 +/- 15 (S.E.) rads, and these represent the most radiosensitive human skin fibroblasts currently available. Representative cell strains from familial retinoblastoma, Fanconi's anemia, and Hutchinson-Gilford progeria occupied positions of intermediate sensitivity, as did one of two ataxia telangiectasia heterozygotes. Six xeroderma pigmentosum cell strains together with two Cockayne's syndrome cell strains (all known to be sensitive to ultraviolet light) fell into the normal range, indicating an absence of cross-sensitivity between ultraviolet light and gamma-irradiation.

Entities:  

Mesh:

Year:  1980        PMID: 7471106

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.

Authors:  P Kannouche; B C Broughton; M Volker; F Hanaoka; L H Mullenders; A R Lehmann
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells.

Authors:  Rugang Zhang; Song-tao Liu; Wei Chen; Michael Bonner; John Pehrson; Timothy J Yen; Peter D Adams
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

3.  Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group.

Authors:  C E Yu; J Oshima; E M Wijsman; J Nakura; T Miki; C Piussan; S Matthews; Y H Fu; J Mulligan; G M Martin; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  In vitro prediction of breast cancer therapy toxicity.

Authors:  Michael J McKay; Jezzie Maneerat; Timothy M McKay; Jeremy N McKay; Reza Masoud-Rahbari
Journal:  Ann Transl Med       Date:  2017-03

5.  Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.

Authors:  Igor Sirák; Zuzana Šinkorová; Mária Šenkeříková; Jiří Špaček; Jan Laco; Hana Vošmiková; Stanislav John; Jiří Petera
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-05

Review 6.  Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations.

Authors:  D Salk
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes.

Authors:  Serah Choi; Rohith Srivas; Katherine Y Fu; Brian L Hood; Banu Dost; Gregory A Gibson; Simon C Watkins; Bennett Van Houten; Nuno Bandeira; Thomas P Conrads; Trey Ideker; Christopher J Bakkenist
Journal:  J Proteome Res       Date:  2012-09-18       Impact factor: 4.466

8.  DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions.

Authors:  M S Satoh; C J Jones; R D Wood; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Studies of cellular radiosensitivity in hereditary disorders of nervous system and muscle.

Authors:  S Brennan; P D Lewis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

10.  Experimental posterior perforating ocular injury: a controlled study of the gross effects of localised gamma irradiation.

Authors:  U Chakravarthy; C J Maguire; D B Archer
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.